User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: A retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)

  1. Ringden O., Outcome after allogeneic bone marrow transplant for leukemia in older adults, 10.1001/jama.270.1.57
  2. Champlin Richard, Khouri Issa, Shimoni Avichai, Gajewski James, Kornblau Steven, Molldrem Jeffrey, Ueno Naoto, Giralt Sergio, Anderlini Paolo, Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy, 10.1046/j.1365-2141.2000.02196.x
  3. Shimoni A, Curr Oncol Rep, 2, 132 (2000)
  4. Shimoni A, Nagler A, Non-myeloablative stem cell transplantation (NST): chimerism testing as guidance for immune-therapeutic manipulations, 10.1038/sj.leu.2402316
  5. Shimoni Avichai, Nagler Arnon, Non-Myeloablative Hematopoietic Stem Cell Transplantation (NST) in the Treatment of Human Malignancies: From Animal Models to Clinical Practice, Non-Myeloablative Allogeneic Transplantation (2002) ISBN:9781461353041 p.113-136, 10.1007/978-1-4615-0919-6_6
  6. Bertz Hartmut, Potthoff Karin, Finke Jürgen, Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors in Older Patients With Myeloid Leukemia, 10.1200/jco.2003.09.110
  7. Giralt S, Blood, 89, 4531 (1997)
  8. McSweeney P. A., Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects, 10.1182/blood.v97.11.3390
  9. Slavin S, Blood, 91, 756 (1998)
  10. Slavin Shimon, Reduced Intensity versus Truly Nonmyeloablative Conditioning for Stem-Cell Transplant Recipients : , 10.1097/01.tp.0000129810.77790.ef
  11. Wong R., Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years, 10.1182/blood-2003-03-0855
  12. Shimoni A, Curr Hematol Rep, 3, 242 (2004)
  13. Alyea E. P., Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age, 10.1182/blood-2004-05-1947
  14. Crawley C., Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT, 10.1182/blood-2004-06-2387
  15. Mohty M, de Lavallade H, Ladaique P, Faucher C, Vey N, Coso D, Stoppa A-M, Gastaut J-A, Blaise D, The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison, 10.1038/sj.leu.2403770
  16. Burroughs Lauri, Storb Rainer, Low-intensity allogeneic hematopoietic stem cell transplantation for myeloid malignancies: separating graft-versus-leukemia effects from graft-versus-host disease : , 10.1097/01.moh.0000148762.05110.56
  17. Hougaard Philip, Frailty models for survival data, 10.1007/bf00985760
  18. Gooley Ted A., Leisenring Wendy, Crowley John, Storer Barry E., Estimation of failure probabilities in the presence of competing risks: new representations of old estimators, 10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.3.co;2-f
  19. Fine JP, J Am Stat Assoc, 94, 496 (1999)
  20. Diaconescu R., Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors, 10.1182/blood-2004-03-0804
  21. Sorror M. L., Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities, 10.1182/blood-2004-02-0545
  22. Chien Jason W., Maris Michael B., Sandmaier Brenda M., Maloney David G., Storb Rainer F., Clark Joan G., Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation, 10.1016/j.bbmt.2005.01.003
  23. Horowitz MM, Blood, 75, 555 (1990)
  24. Ringden O, Leuk Lymphoma, 24, 71 (1996)
  25. Mielcarek M., Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation, 10.1182/blood-2002-08-2628
  26. Flowers M E D, Traina F, Storer B, Maris M, Bethge W A, Carpenter P, Appelbaum F, Storb R, Sandmaier B M, Martin P J, Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning, 10.1038/sj.bmt.1704767
  27. Baron Frédéric, Maris Michael B., Sandmaier Brenda M., Storer Barry E., Sorror Mohamed, Diaconescu Razvan, Woolfrey Ann E., Chauncey Thomas R., Flowers Mary E.D., Mielcarek Marco, Maloney David G., Storb Rainer, Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning, 10.1200/jco.2005.08.136
  28. Couriel Daniel R, Saliba Rima M, Giralt Sergio, Khouri Issa, Andersson Borje, de Lima Marcos, Hosing Chitra, Anderlini Paolo, Donato Michelle, Cleary Karen, Gajewski James, Neumann Joyce, Ippoliti Cindy, Rondon Gabriela, Cohen Agueda, Champlin Richard, Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation, 10.1016/j.bbmt.2003.10.006
  29. Storb R, Leukemia, 15, 662 (2001)
  30. Kerbauy F R, Storb R, Hegenbart U, Gooley T, Shizuru J, Al-Ali H K, Radich J P, Maloney D G, Agura E, Bruno B, Epner E M, Chauncey T R, Blume K G, Niederwieser D, Sandmaier B M, Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML, 10.1038/sj.leu.2403730
  31. Sorror Mohamed L., Maris Michael B., Sandmaier Brenda M., Storer Barry E., Stuart Monic J., Hegenbart Ute, Agura Edward, Chauncey Thomas R., Leis Jose, Pulsipher Michael, McSweeney Peter, Radich Jerald P., Bredeson Christopher, Bruno Benedetto, Langston Amelia, Loken Michael R., Al-Ali Haifa, Blume Karl G., Storb Rainer, Maloney David G., Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Advanced Chronic Lymphocytic Leukemia, 10.1200/jco.2005.04.569
  32. Shimoni A, Leukemia, 19, 7 (2005)
  33. Gorin NC, Bone Marrow Transplant, 18, 111 (1996)
  34. Frassoni Francesco, Labopin Myriam, Powles Ray, Mary Jean-Yves, Arcese William, Bacigalupo Andrea, Bunjes Donald, Gluckman Eliane, Ruutu Tapani, Schaefer Ulrich W, Sierra Jorge, Vernant Jean Paul, Willemze Roel, de Witte Theo, Transplantation Norbert Claude Gorin, Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia, 10.1016/s0140-6736(00)02137-1
Bibliographic reference Aoudjhane, M. ; Labopin, M. ; Gorin, N.C. ; Shimoni, A. ; Ruutu, T. ; et. al. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: A retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT). In: Leukemia, Vol. 19, no. 12, p. 2304-2312 (2005)
Permanent URL http://hdl.handle.net/2078.1/164643